2018
DOI: 10.1016/j.yebeh.2018.04.009
|View full text |Cite
|
Sign up to set email alerts
|

Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy

Abstract: The distribution of AED use likely reflects current prescribing patterns for PWWE cared for in USA tertiary epilepsy centers. This distribution has changed markedly since the turn of the century, but changes in the general population remain uncertain.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
60
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

6
3

Authors

Journals

citations
Cited by 76 publications
(65 citation statements)
references
References 16 publications
4
60
1
Order By: Relevance
“…Mean ± SD gestational ages for conceptions at enrollment were 13.7 ± 4.6 weeks in PWWE and 15.4 ± 3.9 weeks in HPW. The types of epilepsy and the distributions of specific AEDs used in PWWE have been described previously, 3 but are described here briefly. Most PWWE (74%) were on monotherapy, and most had focal epilepsy (62%).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Mean ± SD gestational ages for conceptions at enrollment were 13.7 ± 4.6 weeks in PWWE and 15.4 ± 3.9 weeks in HPW. The types of epilepsy and the distributions of specific AEDs used in PWWE have been described previously, 3 but are described here briefly. Most PWWE (74%) were on monotherapy, and most had focal epilepsy (62%).…”
Section: Resultsmentioning
confidence: 99%
“…This publication describes the occurrence of SAOs (i.e., spontaneous fetal loss and MCMs) in offspring of PWWE vs HPW in the MONEAD study, all of which are secondary outcomes for the MONEAD study. Details of the MONEAD methodology have been published previously, 3 but are represented here in part to allow the reader to more easily interpret the present findings. Participants were enrolled from December 2012 through January 2016 at 20 US epilepsy centers that are specialized in the management of women with epilepsy (WWE) during childbearing years.…”
Section: Designmentioning
confidence: 99%
“…In one study on behavioural outcomes, an increase in certain Management of epilepsy in pregnancy behavioural problems was reported for children (mean age: 6.5 years), as rated by parents, (Huber-Mollema et al, 2019), however, this requires further investigation as there was no direct comparison to a control group. Lamotrigine and levetiracetam have become the most commonly used AEDs in pregnancy in tertiary epilepsy centres in the USA (Meador et al, 2018) and other countries (Kinney et al, 2018). However, data for even these two AEDs are inadequate.…”
Section: Developmental and Behavioural Outcomesmentioning
confidence: 99%
“…Lamotrigine (LTG) is approved for use as chronic therapy in patients with epilepsy and bipolar disorder. It is now the most commonly used antiepileptic drug (AED) across several pregnancy registries and studies . Major physiological changes during pregnancy can lead to significant changes in AED pharmacokinetics, causing possible interruptions in seizure stability.…”
mentioning
confidence: 99%